European Coalition on
Homeopathic & Anthroposophic
Medicinal Products

Sitemap

ECHAMP positions

Support the people's choice About homeopathic and anthroposophic medicinal products: Information for Members of the European Parliament 2019-2024 PDF (142.6 KB)
Letter to the French Minister of Solidarity and Health Concerning the French debate on the reimbursement of homeopathic products PDF (150.3 KB)
Open letter to the attention of Pedro Sánchez, the President of the Government of Spain Concerning the working document presented by María Luisa Carcedo, Minister of Health, Consumers and Social Services and Pedro Duque, Minister of Science, Innovation and Universities in the Instituto de Salud Carlos III on November the 13th, called "PLAN PARA LA PROTECCIÓN DE LA SALUD FRENTE A LAS PSEUDOTERAPIAS" PDF (444.6 KB)
Safety of Homeopathic Medicinal Products (Art. 14 and Art. 16.2) –Calculation of First Safe Dilutions How to assess adequately the safety of homeopathic medicinal products? – Calculation of acceptable amounts based on the assessment of scientific data. PDF (908.7 KB)
Determination of re-test dates of homeopathic intermediate dilutions is a matter of GMP PDF (770.6 KB)
Flexibility Raw Material Suppliers Why raw material suppliers should be defined in the registration dossier only as examples? Flexibility is crucial for availability and without impact on good quality. PDF (798.0 KB)
Open letter to the President of the Spanish Government Concerning the registration process in Spain PDF (225.6 KB)
ECHAMP position on xEVMPD notifications for art. 14 products The pharmacovigilance requirements shall apply to homeopathic medicinal products, with the exception of homeopathic medicinal products registered further to the special, simplified registration procedure under Article 14(1) of Directive 2001/83/EC. PDF (266.8 KB)
ECHAMP response: EASAC Statement on Homeopathic Products and Practices EASAC’s statement seeks to provide a scientific basis for policy making for homeopathic medicinal products in the EU; yet its assessment is based on incomplete knowledge of the current EU regulatory system for these products. Its review of the evidence for homeopathy depends on unreliable reports and studies and contains only second hand scientific analysis. PDF (605.4 KB)